Ionis Pharmaceuticals Impact Investors
Every moment matters in the discovery, development & delivery of life transforming genetic medicines. We are transforming the standard of care & pioneering new markets.
Last Funding Type:
Post-IPO Debt
Funding Status:
IPO
Headquarters:
Carlsbad, California
Founded Date:
1989-01-01
Last Funding Date:
2021-04-08
Total Funding:
751250000.0
Technology:
Biotechnology, Medical, Pharmaceutical
Employee Number:
251-500
Acquisitions Number:
Made Acquisitions
Estimated Revenue:
$100M to $500M
Investors Number:
4
Industry:
Innovation, Technology, and Research